Portfolio company
AMYL THERAPEUTICS
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops pan-amyloid immunotherapies to treat patients with neurodegenerative and rare diseases caused by toxic protein aggregates.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Protego Biopharma
This biotechnology company develops small molecule therapies for patients with systemic amyloid diseases and other protein misfolding disorders.
Alzinova
This biopharmaceutical company develops immunotherapies and vaccines targeting toxic amyloid-beta oligomers to treat and prevent Alzheimer's disease for patients worldwide.
Immutrin
This biotechnology company develops antibody therapies to remove amyloid deposits and treat cardiomyopathy for patients with amyloidosis.
Yumanity Therapeutics
This company develops small molecule drugs to treat neurodegenerative diseases for patients with conditions such as Parkinson's disease and amyotrophic lateral sclerosis.
PharmatrophiX
The company develops small-molecule therapies targeting neurotrophin receptors for patients with Alzheimer's disease and other neurodegenerative disorders.
NeurOdys Therapeutics
This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.
Amylyx Pharmaceuticals
This biotechnology company develops pharmaceutical therapies for people with neurodegenerative and endocrine disorders, including amyotrophic lateral sclerosis and post-bariatric hypoglycemia.
AMAL Therapeutics
The company develops therapeutic vaccines for cancer patients using a proprietary platform to stimulate the immune system and create immunological memory.